BioVie, Inc. (BIVI)
1.43
+0.05
(+3.62%)
USD |
NASDAQ |
Oct 30, 16:00
1.42
-0.01
(-0.70%)
Pre-Market: 20:00
BioVie Price : 1.43 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 1.39 | 1.49 | 1.38 | 1.43 | 105819.0 |
| Oct 29, 2026 | 1.43 | 1.46 | 1.37 | 1.38 | 41873.00 |
| Oct 28, 2026 | 1.49 | 1.49 | 1.412 | 1.46 | 106748.0 |
| Oct 27, 2026 | 1.37 | 1.45 | 1.34 | 1.44 | 196227.0 |
| Oct 26, 2026 | 1.25 | 1.36 | 1.25 | 1.33 | 146569.0 |
| Oct 23, 2026 | 1.28 | 1.30 | 1.23 | 1.24 | 141650.0 |
| Oct 22, 2026 | 1.24 | 1.29 | 1.215 | 1.28 | 101049.0 |
| Oct 21, 2026 | 1.21 | 1.277 | 1.15 | 1.26 | 195074.0 |
| Oct 20, 2026 | 1.40 | 1.45 | 1.24 | 1.24 | 279511.0 |
| Oct 19, 2026 | 1.29 | 1.39 | 1.204 | 1.37 | 182521.0 |
| Oct 16, 2026 | 1.13 | 1.22 | 1.12 | 1.20 | 275926.0 |
| Oct 15, 2026 | 1.18 | 1.19 | 1.13 | 1.13 | 166880.0 |
| Oct 14, 2026 | 1.20 | 1.25 | 1.15 | 1.16 | 342644.0 |
| Oct 13, 2026 | 1.30 | 1.331 | 1.20 | 1.20 | 171968.0 |
| Oct 12, 2026 | 1.41 | 1.441 | 1.31 | 1.32 | 67349.00 |
| Oct 09, 2026 | 1.30 | 1.40 | 1.275 | 1.39 | 204863.0 |
| Oct 08, 2026 | 1.37 | 1.39 | 1.25 | 1.28 | 362157.0 |
| Oct 07, 2026 | 1.46 | 1.47 | 1.40 | 1.40 | 134616.0 |
| Oct 06, 2026 | 1.44 | 1.50 | 1.44 | 1.44 | 132708.0 |
| Oct 05, 2026 | 1.43 | 1.48 | 1.42 | 1.44 | 135119.0 |
| Oct 02, 2026 | 1.47 | 1.52 | 1.46 | 1.46 | 189852.0 |
| Oct 01, 2026 | 1.53 | 1.535 | 1.46 | 1.47 | 266171.0 |
| Sep 30, 2026 | 1.57 | 1.58 | 1.50 | 1.52 | 201339.0 |
| Sep 29, 2026 | 1.55 | 1.61 | 1.52 | 1.54 | 146521.0 |
| Sep 28, 2026 | 1.57 | 1.60 | 1.53 | 1.54 | 182617.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 6.84 |
| Amgen, Inc. | 466.01 |
| Anika Therapeutics, Inc. | 20.95 |
| BioCryst Pharmaceuticals, Inc. | 8.47 |
| Imunon, Inc. | 0.91 |
Price Related Metrics
| Price to Book Value | 1.050 |
| Earnings Yield | -223.6% |
| Market Cap | 10.79M |